Inventor
Cheng LAI
Inventor
US
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes25%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
C12NMicroorganisms or enzymes25%
C12YEnzymes21%
Y02ATechnologies for adaptation to climate change4%
PatentTitleYear
12,534,730Compositions and methods for inhibiting GYS2 expression202611,661,604Methods and compositions for inhibiting expression of LDHA202311,634,715Methods and compositions for treating bile duct paucity-associated conditions202311,572,562Compositions and methods for inhibiting GYS2 expression202311,359,203Therapeutic inhibition of lactate dehydrogenase and agents therefor202211,286,488Methods and compositions for inhibiting expression of LDHA2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2023Patents assigned to DICERNA PHARMACEUTICALS INC (5)· patent assignee history
2022–2026Based in US· patent location history
2026Patents assigned to NOVO NORDISK AS (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| DICERNA PHARMACEUTICALS INC | 5 | 2022–2023 |
| NOVO NORDISK AS | 1 | 2026 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 6 | 2022–2026 |